Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis
01 Pubblicazione su rivista
Sposato B., Scalese M., Camiciottoli G., Carpagnano G. E., Pelaia C., Santus P., Maniscalco M., Corsico A., Grosso A., Baglioni S., Murgia N., Folletti I., Pelaia G., Masieri S., Cavaliere C., Musarra A., Bargagli E., Ricci A., Latorre M., Rogliani P., Paggiaro P.
ISSN: 2590-0412
Nasal polyposis (NP) is a chronic paranasal sinuses inflamma-tory disease causing severe nasal and systemic symptoms includingfatigue, sleeping problems, and impairments in social, emotionaland lifestyle conditions. Patients with severe eosinophilic asthma (SEA) have frequent comorbid NP, which may impact asthma severity.